Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jun 30;9:3975–3983. doi: 10.2147/OTT.S103112

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Yan et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Immunohistochemical results of E-cadherin, TGF-β1, and CD163 in the gastric cancer and paracancer tissue.

Notes: (A) Typical high expression of E-cadherin in paracancer tissue of gastric cancer. Staining was localized predominantly in the cytomembrane. (B) Typical low expression of E-cadherin in gastric cancer tissue. (C) Infrequent high expression of E-cadherin in gastric cancer tissue. (D) Low expression of CD163 in normal tissue. Staining was localized predominantly in the cytosol. (E) Low expression of CD163 in gastric cancer tissue. (F) High expression of CD163 in gastric cancer tissue. (G) Low expression of TGF-β1 in paracancer tissue. Staining was localized predominantly in the cytosol. (H) Low expression of TGF-β1 in gastric cancer. (I) High expression of TGF-β1 in gastric cancer. Magnification, 200×.

Abbreviation: TGF-β1, transforming growth factor-β1.